19 Citations (Scopus)

Abstract

Bradykinin is a multifunctional mediator of inflammation believed to have a role in asthma, a disorder associated with remodeling of extracellular connective tissue. Using contraction of collagen gels as an in vitro model of wound contraction, we assessed the effects of bradykinin tissue on remodeling. Human fetal lung fibroblasts were embedded in type I collagen gels and cultured for 5 days. After release, the floating gels were cultured in the presence of bradykinin. Bradykinin significantly stimulated contraction in a concentration- and time-dependent manner. Coincubation with phosphoramidon augmented the effect of 10-9 and 10-8 M bradykinin. A B2 receptor antagonist attenuated the effect of bradykinin, whereas a B1 receptor antagonist had no effect, suggesting that the effect is mediated by the B2 receptor. An inhibitor of intracellular Ca2+ mobilization abolished the response; addition of EGTA to the culture medium attenuated the contraction of control gels but did not modulate the response to bradykinin. In contrast, the phospholipase C inhibitor U-73122 and the protein kinase C inhibitors staurosporine and GF-109203X attenuated the responses. These data suggest that by augmenting the contractility of fibroblasts, bradykinin may have an important role in remodeling of extracellular matrix that may result in tissue dysfunction in chronic inflammatory diseases, such as asthma.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume281
Issue number1 25-1
StatePublished - Oct 16 2001

Fingerprint

Bradykinin
Collagen
Fibroblasts
Gels
Asthma
Inflammation Mediators
Staurosporine
Protein C Inhibitor
Egtazic Acid
Type C Phospholipases
Protein Kinase Inhibitors
Collagen Type I
Connective Tissue
Protein Kinase C
Extracellular Matrix
Culture Media
Chronic Disease
Lung
Wounds and Injuries

Keywords

  • Asthma
  • Fibroblasts
  • Phospholipase C
  • Three-dimensional collagen gels

ASJC Scopus subject areas

  • Physiology
  • Pulmonary and Respiratory Medicine
  • Physiology (medical)
  • Cell Biology

Cite this

Bradykinin augments fibroblast-mediated contraction of released collagen gels. / Mio, Tadashi; Liu, Xiang-de; Toews, Myron Lee; Adachi, Yuichi; Romberger, Debra; Spurzem, John R.; Rennard, Stephen I.

In: American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 281, No. 1 25-1, 16.10.2001.

Research output: Contribution to journalArticle

@article{4b2335123b3143dabd4c26c4e3d39fe5,
title = "Bradykinin augments fibroblast-mediated contraction of released collagen gels",
abstract = "Bradykinin is a multifunctional mediator of inflammation believed to have a role in asthma, a disorder associated with remodeling of extracellular connective tissue. Using contraction of collagen gels as an in vitro model of wound contraction, we assessed the effects of bradykinin tissue on remodeling. Human fetal lung fibroblasts were embedded in type I collagen gels and cultured for 5 days. After release, the floating gels were cultured in the presence of bradykinin. Bradykinin significantly stimulated contraction in a concentration- and time-dependent manner. Coincubation with phosphoramidon augmented the effect of 10-9 and 10-8 M bradykinin. A B2 receptor antagonist attenuated the effect of bradykinin, whereas a B1 receptor antagonist had no effect, suggesting that the effect is mediated by the B2 receptor. An inhibitor of intracellular Ca2+ mobilization abolished the response; addition of EGTA to the culture medium attenuated the contraction of control gels but did not modulate the response to bradykinin. In contrast, the phospholipase C inhibitor U-73122 and the protein kinase C inhibitors staurosporine and GF-109203X attenuated the responses. These data suggest that by augmenting the contractility of fibroblasts, bradykinin may have an important role in remodeling of extracellular matrix that may result in tissue dysfunction in chronic inflammatory diseases, such as asthma.",
keywords = "Asthma, Fibroblasts, Phospholipase C, Three-dimensional collagen gels",
author = "Tadashi Mio and Xiang-de Liu and Toews, {Myron Lee} and Yuichi Adachi and Debra Romberger and Spurzem, {John R.} and Rennard, {Stephen I.}",
year = "2001",
month = "10",
day = "16",
language = "English (US)",
volume = "281",
journal = "American Journal of Physiology - Renal Physiology",
issn = "0363-6127",
publisher = "American Physiological Society",
number = "1 25-1",

}

TY - JOUR

T1 - Bradykinin augments fibroblast-mediated contraction of released collagen gels

AU - Mio, Tadashi

AU - Liu, Xiang-de

AU - Toews, Myron Lee

AU - Adachi, Yuichi

AU - Romberger, Debra

AU - Spurzem, John R.

AU - Rennard, Stephen I.

PY - 2001/10/16

Y1 - 2001/10/16

N2 - Bradykinin is a multifunctional mediator of inflammation believed to have a role in asthma, a disorder associated with remodeling of extracellular connective tissue. Using contraction of collagen gels as an in vitro model of wound contraction, we assessed the effects of bradykinin tissue on remodeling. Human fetal lung fibroblasts were embedded in type I collagen gels and cultured for 5 days. After release, the floating gels were cultured in the presence of bradykinin. Bradykinin significantly stimulated contraction in a concentration- and time-dependent manner. Coincubation with phosphoramidon augmented the effect of 10-9 and 10-8 M bradykinin. A B2 receptor antagonist attenuated the effect of bradykinin, whereas a B1 receptor antagonist had no effect, suggesting that the effect is mediated by the B2 receptor. An inhibitor of intracellular Ca2+ mobilization abolished the response; addition of EGTA to the culture medium attenuated the contraction of control gels but did not modulate the response to bradykinin. In contrast, the phospholipase C inhibitor U-73122 and the protein kinase C inhibitors staurosporine and GF-109203X attenuated the responses. These data suggest that by augmenting the contractility of fibroblasts, bradykinin may have an important role in remodeling of extracellular matrix that may result in tissue dysfunction in chronic inflammatory diseases, such as asthma.

AB - Bradykinin is a multifunctional mediator of inflammation believed to have a role in asthma, a disorder associated with remodeling of extracellular connective tissue. Using contraction of collagen gels as an in vitro model of wound contraction, we assessed the effects of bradykinin tissue on remodeling. Human fetal lung fibroblasts were embedded in type I collagen gels and cultured for 5 days. After release, the floating gels were cultured in the presence of bradykinin. Bradykinin significantly stimulated contraction in a concentration- and time-dependent manner. Coincubation with phosphoramidon augmented the effect of 10-9 and 10-8 M bradykinin. A B2 receptor antagonist attenuated the effect of bradykinin, whereas a B1 receptor antagonist had no effect, suggesting that the effect is mediated by the B2 receptor. An inhibitor of intracellular Ca2+ mobilization abolished the response; addition of EGTA to the culture medium attenuated the contraction of control gels but did not modulate the response to bradykinin. In contrast, the phospholipase C inhibitor U-73122 and the protein kinase C inhibitors staurosporine and GF-109203X attenuated the responses. These data suggest that by augmenting the contractility of fibroblasts, bradykinin may have an important role in remodeling of extracellular matrix that may result in tissue dysfunction in chronic inflammatory diseases, such as asthma.

KW - Asthma

KW - Fibroblasts

KW - Phospholipase C

KW - Three-dimensional collagen gels

UR - http://www.scopus.com/inward/record.url?scp=0034804382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034804382&partnerID=8YFLogxK

M3 - Article

VL - 281

JO - American Journal of Physiology - Renal Physiology

JF - American Journal of Physiology - Renal Physiology

SN - 0363-6127

IS - 1 25-1

ER -